FDA Inspection 1180645 — MRIGlobal
The FDA completed an inspection of MRIGlobal on Aug 26, 2022 in North Kansas City, MO. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Aug 26, 2022
- Fiscal Year
- 2022
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- North Kansas City, MO (United States)